RARRES2 and irritable bowel syndrome: Collectively, these insights position chemerin as a regulator that exerts context-dependent effects in experimental IBD: harmful when it obstructs macrophage-mediated inflammation resolution, but beneficial when it supports epithelial antimicrobial activity and microbial stability.